Evidence Hub

Childbirth Experiences in Women With Polycystic Ovary Syndrome: A Cohort Study

Ã. Husby, Simpson, R. Dalbye, M. Larsen, E. Vanky, TS Løvvik

Obstetric Anesthesia Digest, 2025

Abstract

(Acta Obstet Gynecol Scand. 2024;103(6):1092–1100. doi:10.1111/aogs.14800)

Polycystic ovary syndrome (PCOS) is a complicated disorder with 4 different types, impacting 5% to 20% of females based on diagnostic standards and the specific group being examined. It is linked with various other health conditions, such as metabolic syndrome, type 2 diabetes, insulin resistance, obesity, and cardiovascular risks, as well as psychological issues like anxiety and depression. Matters related to reproduction, like gestational diabetes, premature birth, and cesarean delivery, are frequently seen. Metformin, a drug for diabetes, is commonly utilized to enhance insulin sensitivity and has been proven to lower rates of preterm births and late miscarriages in PCOS patients, but it does not prevent gestational diabetes.

How strong is the evidence?

Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free